Nanoparticle Therapy Targets Lung Cancer and Muscle Wasting Simultaneously
Researchers have developed lipid nanoparticles that deliver mRNA therapeutics to simultaneously treat lung cancer and associated muscle wasting. The nanoparticles target lung tumors while preserving muscle mass, showing 2.5 times greater tumor reduction in preclinical models. This dual-action approach addresses both the primary tumor and debilitating cachexia syndrome.